The synthesis and structural characterization of the novel homoleptic cluster complexes [Pd2(GaCp*)2(mu2-GaCp*)3] (1c), [Pd3(GaCp*)4(mu2-GaCp*)4] (2b) and [Pd3(AlCp*)2(mu2-AlCp*)2(mu3-AlCp*)2] (3) (Cp*=C5Me5) are presented. Furthermore, ligand exchange reactions of these cluster complexes are explored. In contrast to the electronically and sterically saturated complexes [M(ECp*)4] (M=Ni, Pd, Pt), the new unsaturated analogues [M(a)(ER)b] (E=Al, Ga, In) react with a variety of typical ligands (Cp*Al, CO, phosphines, isonitriles) to give new di- and tri-substituted compounds like [Pt2(GaCp*)2(mu2-AlCp*)3] (1d), [PdPt(GaCp*)(PPh3)(mu2-GaCp*)3] (4b), or [Pd3(PPh3)3(mu2-InCp*)(mu3-InCp*)2] (8). The trends of the reactivity of [M(a)(ER)b] as well as their fluxional behavior in solution has been elucidated by NMR spectroscopy, resulting in a mechanistic rationale for the ligand exchange reactions as well as the fluxional processes.
No takes yet. Share an insight, caveat, or question.
Steinke et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: